FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1240358000: Product containing precisely levamlodipine (as levamlodipine besilate) 2.5 milligram and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug)


Status: current, Defined. Date: 30-Sep 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5110516012 Product containing precisely levamlodipine (as levamlodipine besilate) 2.5 milligram and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) en Fully specified name Active Initial character case insensitive SNOMED CT core
5110517015 Levamlodipine (as levamlodipine besylate) 2.5 mg and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet en Synonym Active Initial character case insensitive SNOMED CT core
5110518013 Levamlodipine (as levamlodipine besilate) 2.5 mg and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet en Synonym Active Initial character case insensitive SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Levamlodipine (as levamlodipine besilate) 2.5 mg and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet Has manufactured dose form Conventional release and prolonged-release oral tablet true Inferred relationship Some
Levamlodipine (as levamlodipine besilate) 2.5 mg and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet Has unit of presentation Tablet true Inferred relationship Some
Levamlodipine (as levamlodipine besilate) 2.5 mg and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet Has precise active ingredient Levamlodipine besilate true Inferred relationship Some 1
Levamlodipine (as levamlodipine besilate) 2.5 mg and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet Has BoSS Levamlodipine true Inferred relationship Some 1
Levamlodipine (as levamlodipine besilate) 2.5 mg and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 1
Levamlodipine (as levamlodipine besilate) 2.5 mg and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 1
Levamlodipine (as levamlodipine besilate) 2.5 mg and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet Has precise active ingredient (S)-metoprolol succinate true Inferred relationship Some 2
Levamlodipine (as levamlodipine besilate) 2.5 mg and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet Has BoSS (S)-metoprolol tartrate true Inferred relationship Some 2
Levamlodipine (as levamlodipine besilate) 2.5 mg and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 2
Levamlodipine (as levamlodipine besilate) 2.5 mg and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 2
Levamlodipine (as levamlodipine besilate) 2.5 mg and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet Is a Levamlodipine and metoprolol only product in oral dose form true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start